-+ 0.00%
-+ 0.00%
-+ 0.00%

Vir Biotechnology Appoints Aziz Sawaf CFO, Effective Oct. 5

Benzinga·10/01/2026 12:35:25
Listen to the news

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Aziz Sawaf, MBEE, MBA, CFA, as Executive Vice President and Chief Financial Officer (CFO), effective October 5, 2026. Mr. Sawaf will be responsible for leading the finance, IT and investor relations functions.